Rossari Biotech Balance Sheet Health
Financial Health criteria checks 5/6
Rossari Biotech has a total shareholder equity of ₹9.8B and total debt of ₹1.3B, which brings its debt-to-equity ratio to 13.5%. Its total assets and total liabilities are ₹15.3B and ₹5.6B respectively. Rossari Biotech's EBIT is ₹1.7B making its interest coverage ratio 9.3. It has cash and short-term investments of ₹791.1M.
Key information
13.5%
Debt to equity ratio
₹1.32b
Debt
Interest coverage ratio | 9.3x |
Cash | ₹791.08m |
Equity | ₹9.78b |
Total liabilities | ₹5.56b |
Total assets | ₹15.34b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 543213's short term assets (₹8.4B) exceed its short term liabilities (₹4.7B).
Long Term Liabilities: 543213's short term assets (₹8.4B) exceed its long term liabilities (₹871.9M).
Debt to Equity History and Analysis
Debt Level: 543213's net debt to equity ratio (5.4%) is considered satisfactory.
Reducing Debt: 543213's debt to equity ratio has increased from 7.5% to 13.5% over the past 5 years.
Debt Coverage: 543213's debt is well covered by operating cash flow (48%).
Interest Coverage: 543213's interest payments on its debt are well covered by EBIT (9.3x coverage).